The EU's medicines regulator says unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19.
After a study into dozens of cases in the EU, the European Medicines Agency concluded the benefits of the vaccine outweighed the risk.
There was no definite causal link and though most cases were in women under 60, they also occurred in men.
It studied 86 blood clot cases. The EU has vaccinated over 20 million people.
The EU's medicines regulator says unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19.
After a study into dozens of cases in the EU, the European Medicines Agency concluded the benefits of the vaccine outweighed the risk.
There was no definite causal link and though most cases were in women under 60, they also occurred in men.
It studied 86 blood clot cases. The EU has vaccinated over 20 million people.